All lobbying filings

EVONIK CORPORATION

Lobbying for EVONIK CORPORATION · Manufacturer of specialty chemicals

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $60,000.00 income · posted Apr 20, 2026

Official filing document

Bills named in this filing 2

HR 6938
Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026
S 4221
Ensuring Better Interest Treatment and Deductibility Act (EBITDA)

Lobbying activity 7

Trade (domestic/foreign)

Issues related to various trade agreement discussions USMCA Review Process

Chemicals/Chemical Industry

Issues related to TSCA reform H.R.0000/S.0000 (discussion drafts) - To reauthorize the Toxic Substances Control Act, and for other purposes Issues related to EPA Premanufacturing Notices Issues related to new chemical reviews PFAS/PFOA oversight and regulatory efforts D4 Draft Risk Evaluation

Environment/Superfund

Oversight of EPA rules and regulations Make American Healthy Again (MAHA) GRAS issue

Budget/Appropriations

H.R.6938 - Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026, (Public Law 119-74) FY27 Appropriations Actions

Taxation/Internal Revenue Code

General issues related to corporate tax S. 4221 - Ensuring Better Interest Treatment and Deductibility Act (EBITDA)

Railroads

Issues related to the Surface Transportation Board (STB) and rail mergers

Tariff (miscellaneous tariff bills)

Issues related to the Administrations tariff actions and related Congressional oversight

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.